Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07692217 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

TG-INSIGHT With Joint POCUS, Hemostatic Potential in Patients With Severe Hemophilia A on Novel Replacement and Substitution FVIII Therapies

Name: TG-INSIGHT With Joint POCUS, Hemostatic Potential in Patients With Severe Hemophilia A on Novel Replacement and Substitution FVIII Therapies — clinical trial record (NCT07692217)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhaseNot specified

SponsorUniversity of Texas Southwestern Medical Center

Started2026-07-22

View on ClinicalTrials.gov ↗

Amendment history

2026-09-30

Recruitment opened

University of Texas Southwestern Medical Center

297 trials monitored

See 22 trials at risk

Hemophilia

231 trials monitored

See 10 trials at risk

This is an observational research study to find out if there is a difference in the way children with moderate or severe hemophilia A, treated on two different types of factor replacement, form a clot and also evaluate if they develop tiny bleeds within the joint and subsequently early joint changes when receiving extended half-life factor VIII.

Trial Details

NCT Number	NCT07692217
Lead Sponsor	University of Texas Southwestern Medical Center Collaborators: Sanofi
Conditions	Hemophilia A, Factor VIII (FVIII)
Enrollment	60 participants
Start Date	2026-07-22
Primary Completion	2033-05 (estimated)
Study Completion	2033-05 (estimated)
Updated on ClinicalTrials.gov	2026-09-29